Skip to main content
Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.22
-0.07 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
10.24
+0.02 (0.20%)
Pre-market: Apr 29, 2026, 6:34 AM EDT

Arvinas Revenue

In the year 2025, Arvinas had annual revenue of $262.60M, down -0.30%. Arvinas had revenue of $9.50M in the quarter ending December 31, 2025, a decrease of -83.95%.

Revenue (ttm)
$262.60M
Revenue Growth
-0.30%
P/S Ratio
2.49
Revenue / Employee
$1,067,480
Employees
246
Market Cap
653.68M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025262.60M-800.00K-0.30%
Dec 31, 2024263.40M184.90M235.54%
Dec 31, 202378.50M-52.90M-40.26%
Dec 31, 2022131.40M77.80M145.15%
Dec 31, 202153.60M27.70M106.95%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CorMedix 311.71M
Gyre Therapeutics 116.59M
Zevra Therapeutics 106.47M
Lexicon Pharmaceuticals 49.80M
Prothena Corporation 9.68M
Aclaris Therapeutics 7.83M
Prime Medicine 4.63M
Revenue Rankings

ARVN News

More News